AstraZeneca | Investor Day Presentation Deck

Slide schematic 8/8

list 2/2 metric 4/4 source-note 1/1 title 1/1

Components 8

bullet bullet big-number big-number big-number big-number source-note headline

Tools 1

The slide presents a comparison between the current state and the potential future state of TOPAZ-1 as the first-ever IO therapy available for first-line, advanced biliary tract cancer patients.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

before-after-framing 100%

Contrasts the 'Lack of innovation' (problem) with 'TOPAZ-1 has practice-changing potential' (solution).

Find anything

Uses a before-after framing to contrast the status quo (problem) with the new clinical solution.